(Total Views: 480)
Posted On: 02/14/2020 12:22:41 PM
Post# of 154003
Quote:
Any other company would have had its SP go to-da-moon.
That's the source of my frustration.
There *was* fresh news in this PR and even most longs are inexplicably yawning despite further proof that Leronlimab's effectiveness is really quite earth-shattering. Now we know more patients have been jabbed and EVERY patient thus far has improved by a remarkable degree or their illness has plateaued.
Like you said, any other company would have skyrocketed. If this was a marijuana penny stock and they announced a new strain that got you an extra 5 minutes of feeling high, the PPS would have soared over $2.
Meanwhile, we have MMs battling over a penny or two.
(1)
(0)
